RecruitingPhase 3NCT07215767

Clinical Study to Investigate the Antihypersensitivity Efficacy of a Novel Dentifrice


Sponsor

HALEON

Enrollment

850 participants

Start Date

Sep 16, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of this clinical study is to demonstrate the superior antihypersensitivity efficacy of a novel stannous fluoride (SnF2) and potassium nitrate (KNO3) dentifrice (Investigational Product), compared to SnF2 only, KNO3 only and Vehicle dentifrices, after 8 weeks twice daily use.


Eligibility

Min Age: 12 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Potassium nitrate Dentifrice, a drug called Stannous fluoride Dentifrice, and others for people with dentin hypersensitivity. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 12 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGStannous fluoride and Potassium nitrate Dentifrice

Fluoride dentifrice

DRUGStannous fluoride Dentifrice

Fluoride dentifrice

DRUGPotassium nitrate Dentifrice

Non-fluoride dentifrice

DRUGVehicle Dentifrice

Placebo dentifrice


Locations(3)

All Sum Research Limited

Melbourne, Florida, United States

Salus Research, Inc.

Fort Wayne, Indiana, United States

Silverstone Research

Las Vegas, Nevada, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07215767


Related Trials